These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts. Bonkowsky HL, Tschudy DP, Weinbach EC, Ebert PS, Doherty JM. J Lab Clin Med; 1975 Jan; 85(1):93-102. PubMed ID: 1141734 [Abstract] [Full Text] [Related]
6. The neurological manifestations of porphyria: a review. Becker DM, Kramer S. Medicine (Baltimore); 1977 Sep; 56(5):411-23. PubMed ID: 329053 [Abstract] [Full Text] [Related]
7. Respiratory insufficiency associated with acute hepatic porphyria. Wongthim S, Hemachudha T, Punthumchinda K. J Med Assoc Thai; 1989 Nov; 72(11):655-9. PubMed ID: 2635211 [Abstract] [Full Text] [Related]
9. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E, Harper P, Andersson DE, Floderus Y. Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [Abstract] [Full Text] [Related]
10. Hepatic porphyrias: new findings on the nature of metabolic defects. Meyer UA. Prog Liver Dis; 1976 Mar; 5():280-93. PubMed ID: 775544 [No Abstract] [Full Text] [Related]
14. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers]. Tasnádi G, Bor M, Pusztai A. Orv Hetil; 2003 May 11; 144(19):933-8. PubMed ID: 12809070 [Abstract] [Full Text] [Related]